Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 5
2012 4
2013 4
2014 12
2015 8
2016 4
2017 4
2018 5
2019 5
2020 12
2021 13
2022 5
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS, Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA III, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Eskander RN, et al. N Engl J Med. 2023 Mar 27. doi: 10.1056/NEJMoa2302312. Online ahead of print. N Engl J Med. 2023. PMID: 36972022
Practice changing cervical cancer clinical trials.
Pothuri B, Eskander RN, Randall LM, O'Malley DM, Slomovitz B, Moore KN, Herzog TJ, Coleman RL, Copeland LJ, Monk BJ. Pothuri B, et al. Among authors: eskander rn. Gynecol Oncol. 2022 Jun;165(3):410-412. doi: 10.1016/j.ygyno.2022.03.004. Epub 2022 Apr 20. Gynecol Oncol. 2022. PMID: 35461731 No abstract available.
PARP Inhibitors in Epithelial Ovarian Cancer.
Taylor KN, Eskander RN. Taylor KN, et al. Among authors: eskander rn. Recent Pat Anticancer Drug Discov. 2018;13(2):145-158. doi: 10.2174/1574892813666171204094822. Recent Pat Anticancer Drug Discov. 2018. PMID: 29205122 Review.
Immunotherapy toxicities: An SGO clinical practice statement.
O'Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, Pothuri B. O'Cearbhaill RE, et al. Among authors: eskander rn. Gynecol Oncol. 2022 Jul;166(1):25-35. doi: 10.1016/j.ygyno.2022.05.003. Epub 2022 May 18. Gynecol Oncol. 2022. PMID: 35597686 No abstract available.
Targeting angiogenesis in advanced cervical cancer.
Eskander RN, Tewari KS. Eskander RN, et al. Ther Adv Med Oncol. 2014 Nov;6(6):280-92. doi: 10.1177/1758834014543794. Ther Adv Med Oncol. 2014. PMID: 25364393 Free PMC article. Review.
Clinical trials, adaptability and the COVID-19 pandemic.
Eskander RN, Pothuri B, Randall L, O'Malley D, Slomovitz B, Moore K, Coleman R, Herzog T, Monk BJ, Copeland L. Eskander RN, et al. Gynecol Oncol Rep. 2021 Feb;35:100680. doi: 10.1016/j.gore.2020.100680. Epub 2020 Dec 8. Gynecol Oncol Rep. 2021. PMID: 33319009 Free PMC article.
76 results